Bottom line
How much do PHSYX and SWHFX overlap?
64% of their top holdings overlap by weight. 14 securities appear in both funds' top 25, making up 64.4% of PHSYX's assets and 56.8% of SWHFX's. They share a meaningful core but differ in the rest of the portfolio.
Updated Nov 22, 2026
Overlap at a glance
Holdings PHSYX and SWHFX have in common
| Holding | % of PHSYX | % of SWHFX | Overlap |
|---|---|---|---|
| Eli Lilly & Co. | 13.15% | 13.92% | 13.15% |
| Johnson & Johnson | 8.46% | 6.94% | 6.94% |
| UnitedHealth Group, Inc. | 6.93% | 4.74% | 4.74% |
| AbbVie, Inc. | 6.05% | 5.81% | 5.81% |
| Novartis AG | 5.13% | 2.92% | 2.92% |
| Merck & Co., Inc. | 4.88% | 4.98% | 4.88% |
| Thermo Fisher Scientific, Inc. | 4.50% | 2.16% | 2.16% |
| Sanofi SA | 3.23% | 1.31% | 1.31% |
| Roche Holding AG | 2.79% | 2.29% | 2.29% |
| Gilead Sciences, Inc. | 2.63% | 3.24% | 2.63% |
| Vertex Pharmaceuticals, Inc. | 1.97% | 1.89% | 1.89% |
| Boston Scientific Corp. | 1.80% | 1.60% | 1.60% |
| Bristol-Myers Squibb Co. | 1.75% | 2.44% | 1.75% |
| Amgen, Inc. | 1.11% | 2.58% | 1.11% |
Source: SEC Form N-PORT (periods May 31, 2026 / Jul 31, 2026)
Free weekly newsletter
The Fund Letter
Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.
Free. Unsubscribe anytime. We never sell your email.
What each fund holds that the other doesn't
Top-25 holdings that appear in only one of the two funds' top 25.
Only in PHSYX
- AstraZeneca plc — 4.67%
- Intuitive Surgical, Inc. — 4.04%
- Edwards Lifesciences Corp. — 2.80%
- CVS Health Corp. — 2.74%
- McKesson Corp. — 2.14%
- Cardinal Health, Inc. — 2.12%
- Novo Nordisk A/S — 1.90%
- Dexcom, Inc. — 1.64%
- Hoya Corp. — 1.52%
- Putnam Short Term Investment Fund — 1.35%
- HCA Healthcare, Inc. — 1.18%
Only in SWHFX
- Medtronic PLC — 2.29%
- Stryker Corp — 2.11%
- Gsk Plc — 1.73%
- Abbott Laboratories — 1.60%
- Cigna Group/The — 1.51%
- Danaher Corp — 1.47%
- Elevance Health Inc — 1.45%
- Incyte Corp — 1.37%
- Ipsen SA — 1.34%
- Becton Dickinson & Co — 1.24%
- Astellas Pharma Inc — 1.19%
Asset mix
| Asset type | PHSYX | SWHFX |
|---|---|---|
| Stocks | 98.2% | 99.0% |
| Other | 1.4% | — |
| Cash & short-term funds | 0.6% | — |
Source: SEC Form N-PORT (periods May 31, 2026 / Jul 31, 2026)
Country mix
| Country | PHSYX | SWHFX |
|---|---|---|
| US | 76.2% | 78.6% |
| CH | 7.9% | 5.2% |
| GB | 6.4% | 3.4% |
| IE | — | 4.5% |
| FR | 3.2% | 2.6% |
| DK | 2.4% | 0.7% |
| JP | 2.4% | 2.3% |
| NL | 1.2% | 0.7% |
Source: SEC Form N-PORT (periods May 31, 2026 / Jul 31, 2026)
Check another pair
FAQ
How much do PHSYX and SWHFX overlap?
What stocks do PHSYX and SWHFX have in common?
Should I own both PHSYX and SWHFX?
Which holds more stocks, PHSYX or SWHFX?
Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.